Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice.

Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice. Abstract Text:

Yasunori Iwashima,Mizuho Okada,Masakazu Haneda,Takeshi Yoshida,

Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice. Publishing Authors By Initials

Y Iwashima,M Okada,M Haneda,T Yoshida,

For similar heterocyclic compounds: heterocyclic compounds, 1-ring: azoles: tetrazoles research abstracts see: heterocyclic compounds: heterocyclic compounds, 1-ring: azoles: tetrazoles research

PUBMED ID PMID:

MEDLINE DATE:

Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice. Journal Published:

PUBLICATION TYPE: Letter

Journal: Diabetes research and clinical practice

VOLUME: 77

Page Numbers: 492-3

Journal Abbreviation: Diabetes Res. Clin. Pract.

ISSN: 0168-8227

DAY: 16

MONTH: 02

YEAR: 2007

Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8508335

Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice. Keywords Mesh Terms:

KEYWORDS: Tetrazoles

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice. Information

Substance Name: candesartan

Registry Number: 139481-59-7

Grant and Affiliation Information for Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice.

AFFILIATION:

Country: Ireland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Diabetes Res Clin Pract

REFSOURCE: Diabetes Res Clin Pract. 2006 Oct;74(1):

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice Related Publications

• Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population.
• Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice.
• Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice.
• [Acute renal function deterioration in a Coronary Unit in Spain.]